Trial Profile
Chemoembolisation With Irinotecan Loaded DC Bead in Combination With Cetuximab and 5FU/LV in the First Line Treatment of Patients With KRAS Wildtype Metastatic Colorectal Cancer
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase II
Latest Information Update: 28 Sep 2022
Price :
$35
*
At a glance
- Drugs Cetuximab (Primary) ; Fluorouracil (Primary) ; Irinotecan (Primary)
- Indications Adenocarcinoma; Colorectal cancer; Liver metastases
- Focus Adverse reactions
- 03 Dec 2014 Status changed from not yet recruiting to withdrawn prior to enrolment, as reported by ClinicalTrials.gov record.
- 05 Jul 2012 New trial record